← Leaderboards
Aaron K Olson
Seattle Children'S Hospital
$5,767,920
Attributed
$5,767,920
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $832K · FY2009–25$1M$750K$500K$250K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,767,920 · 3
By mechanism
R01$5,123,025 · 2
K08$644,895 · 1
Top collaborators
No co-investigators on record.
Most similar at Seattle Children'S Hospital
Same institution · by research overlap
- David R. Beier$33,594,362
- Nicholas W Chavkin$416,610
Others in their field
Top investigators on “Mediating”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Lawrence Corey · Fred Hutchinson Cancer Center$493,822,581
- Barton F Haynes · Duke University$295,802,493
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$286,700,869
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$176,977,598
- Dan H. Barouch · Fred Hutchinson Cancer Center$122,734,499
Research focus
MediatingEvaluationCessation Of LifeDisabilityPressureMetabolicResponseHypertrophyHeart HypertrophyCardiacMetabolismHeart FailureLinkSignal TransductionFinancial CompensationMyocardialAortic Valve StenosisAffectInsightHeart FunctionHeartGlycolysisHeart MetabolismGenerations
Grant awards (13)
Hexosamine biosynthesis pathway metabolism during cardiac hypertrophy$817,138
R01 · FY2025 · HL · contact PI
Hexosamine biosynthesis pathway metabolism during cardiac hypertrophy$831,972
R01 · FY2024 · HL · contact PI
Hexosamine biosynthesis pathway metabolism during cardiac hypertrophy$750,797
R01 · FY2023 · HL · contact PI
Metabolic regulation of O-GlcNAc and cardiac function during hypertrophy$509,443
R01 · FY2019 · HL · contact PI
Metabolic regulation of O-GlcNAc and cardiac function during hypertrophy$558,626
R01 · FY2018 · HL · contact PI
Metabolic regulation of O-GlcNAc and cardiac function during hypertrophy$555,158
R01 · FY2017 · HL · contact PI
Metabolic regulation of O-GlcNAc and cardiac function during hypertrophy$566,001
R01 · FY2016 · HL · contact PI
Metabolic regulation of O-GlcNAc and cardiac function during hypertrophy$533,890
R01 · FY2015 · HL · contact PI
Metabolic Substrate Utilization During c-Myc Induced Cardiac Hypertrophy$128,979
K08 · FY2013 · HL · contact PI
Metabolic Substrate Utilization During c-Myc Induced Cardiac Hypertrophy$128,979
K08 · FY2012 · HL · contact PI
Metabolic Substrate Utilization During c-Myc Induced Cardiac Hypertrophy$128,979
K08 · FY2011 · HL · contact PI
Metabolic Substrate Utilization During c-Myc Induced Cardiac Hypertrophy$128,979
K08 · FY2010 · HL · contact PI
Metabolic Substrate Utilization During c-Myc Induced Cardiac Hypertrophy$128,979
K08 · FY2009 · HL · contact PI